ASM Microbe 2018

Click to view our ASM presentations.


Share Price

35.50p 0.00
at 04:29pm GMT 14 Aug 2018

$2.25 -0.10
at 04:00pm ET 14 Aug 2018

Current Programmes

  • C. difficile Infection

    Clostridium difficile infection (‘CDI’) is a major healthcare issue in hospitals, long-term care homes, and increasingly in the wider community. It is a serious illness caused by infection of the colon by the bacteria, C. difficile, which produces toxins that cause inflammation, severe diarrhoea and can in the most serious of cases be fatal.

    Read More
  • C. Difficile Infections banner image


    Gonorrhoea has been identified as one of three urgent threats by the US Centers for Disease Control and Prevention and a high priority pathogen by the World Health Organisation.

    We are developing new mechanism antibiotics for the treatment of all gonorrhoea.

    Read More
  • Discuva Platform

    The world is entering an era of untreatable infections. Without urgent action, once easily curable infections could become global health crises.

    Summit's approach to tackling this problem is the development of new mechanism antibiotics and is using its proprietary Discuva Platform as part of its research activities.

    Read More